NF1 and inflammatory myofibroblastic tumor: They were ARID1A (tazemetostat, PLX2853), NF1 (trametinib, cobimetinib) and PTEN (GSK2636771, AZD8186) in three IMT patients, and KRAS (trametinib, cobimetinib, binimetinib) in one MT patient (Table S9).